Cancer BiologybioRxivPreprint
Defective Nucleotide Catabolism Defines a Subset of Cancers Sensitive to Purine Nucleoside Phosphorylase Inhibition
E. R. Abt, V. Lok, T. M. Le…·C. G. Radu
This study identifies SAMHD1, dCK, and CDA as biomarkers for predicting sensitivity to PNP inhibitors in cancers, showing that PNP inhibition can target both hematological and solid tumors.
DOI 10.1101/810093